Haemoglobin-S testing for the Welsh Blood Service comes from Abbott
- NHS Wales Shared Services Partnership
- Wales
- Open, 1 bid
- 1 April 2026 to 31 March 2031
NHS Wales Shared Services Partnership awarded Abbott a £98,000 managed service contract for Haemoglobin-S testing, about a third of its £300,000 estimate.
The testing is for the Welsh Blood Service, part of Velindre University NHS Trust, which supplies blood components to hospitals across NHS Wales. Red cells from donors with sickle cell trait are safe for most patients. Patients with sickle cell disease, newborns and children are the exception, because of a higher risk of the cells sickling. The testing picks out donations that carry the trait.
Abbott supplies the testing equipment and support. It was the only bidder in an open tender that weighted cost at 60% and the technical offer at 40%, and won in February 2026. The contract runs to March 2031, with two optional one-year extensions.
Contract ends March 2031
- What
- Blood transfusion laboratory systems
- Supplier
- Abbott
- Value
- £98,000
- How it was bought
- Open
- 1 bid
- Dates and next
- Apr 2026 to Mar 2031
- Option to Mar 2033